IDEXX Laboratories Inc (IDXX)
516.50
+0.40
(+0.08%)
USD |
NASDAQ |
May 24, 16:00
516.88
+0.38
(+0.07%)
After-Hours: 20:00
IDEXX Laboratories Cash from Investing (Quarterly): -106.94M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -106.94M |
December 31, 2023 | -30.44M |
September 30, 2023 | -27.84M |
June 30, 2023 | -27.47M |
March 31, 2023 | -39.51M |
December 31, 2022 | -49.23M |
September 30, 2022 | -49.20M |
June 30, 2022 | -55.09M |
March 31, 2022 | -41.84M |
December 31, 2021 | -44.04M |
September 30, 2021 | -49.68M |
June 30, 2021 | -174.66M |
March 31, 2021 | -24.59M |
December 31, 2020 | -15.69M |
September 30, 2020 | -19.46M |
June 30, 2020 | -24.56M |
March 31, 2020 | -49.67M |
December 31, 2019 | -95.91M |
September 30, 2019 | -37.33M |
June 30, 2019 | -34.08M |
March 31, 2019 | -38.21M |
December 31, 2018 | -39.84M |
September 30, 2018 | -54.22M |
June 30, 2018 | -27.65M |
March 31, 2018 | 260.31M |
Date | Value |
---|---|
December 31, 2017 | -24.49M |
September 30, 2017 | -41.49M |
June 30, 2017 | -43.70M |
March 31, 2017 | -29.01M |
December 31, 2016 | -14.28M |
September 30, 2016 | -22.95M |
June 30, 2016 | -29.76M |
March 31, 2016 | -23.80M |
December 31, 2015 | -26.01M |
September 30, 2015 | -54.81M |
June 30, 2015 | -66.97M |
March 31, 2015 | -160.62M |
December 31, 2014 | -35.62M |
September 30, 2014 | -23.45M |
June 30, 2014 | -8.712M |
March 31, 2014 | -12.63M |
December 31, 2013 | -16.98M |
September 30, 2013 | -25.74M |
June 30, 2013 | -26.05M |
March 31, 2013 | -17.29M |
December 31, 2012 | -17.05M |
September 30, 2012 | -18.93M |
June 30, 2012 | -14.81M |
March 31, 2012 | -7.344M |
December 31, 2011 | -54.90M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-174.66M
Minimum
Jun 2021
-15.69M
Maximum
Dec 2020
-49.86M
Average
-40.67M
Median
Cash from Investing (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | -1.687B |
Steris PLC | -95.61M |
Zoetis Inc | -131.00M |
ResMed Inc | -33.15M |
Vertex Pharmaceuticals Inc | -2.136B |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 198.58M |
Cash from Financing (Quarterly) | -144.07M |
Free Cash Flow | 796.79M |
Free Cash Flow Per Share (Quarterly) | 2.005 |
Free Cash Flow to Equity (Quarterly) | 170.42M |
Free Cash Flow to Firm (Quarterly) | 171.09M |
Free Cash Flow Yield | 1.84% |